(NASDAQ: IRMD) Iradimed's forecast annual revenue growth rate of 13.33% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 9.78%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 19.61%.
Iradimed's revenue in 2025 is $71,305,130.On average, 1 Wall Street analysts forecast IRMD's revenue for 2025 to be $1,024,140,767, with the lowest IRMD revenue forecast at $1,024,140,767, and the highest IRMD revenue forecast at $1,024,140,767.
In 2026, IRMD is forecast to generate $1,254,417,190 in revenue, with the lowest revenue forecast at $1,254,417,190 and the highest revenue forecast at $1,254,417,190.